文献速递脑血管病

既往卒中患者血压变异性与心血管结局:PRoFESS试验二次分析

Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS.
PubMed 文献 · Stroke · 2019-09-20

结果显示收缩压和舒张压BPV均与复发性卒中、主要心血管事件及全因死亡相关,且与缺血性卒中的关联显著,与出血性卒中无关。BPV每增加10点(收缩压SD,范围0-54.2),复发性缺血性卒中风险比1.15(95%CI 1.02-1.32;P=0.02),主要心血管事件风险比1.19(95%CI 1.09-1.31;P<0.001),全因死亡风险比1.24(95%CI 1.10-1.39;P<0.001)。

要点

  • 收缩压和舒张压BPV均与复发性卒中、主要心血管事件及全因死亡相关。
  • BPV与缺血性卒中的关联显著,与出血性卒中无关。
  • BPV每增加10点,复发性缺血性卒中风险增加15%,主要心血管事件风险增加19%,全因死亡风险增加24%。

核心结论

  • BPV是缺血性卒中、心血管事件和全因死亡的重要且可能可改变的风险因素。
  • 本研究首次证明BPV升高与复发性缺血性卒中相关,且舒张压BPV与收缩压BPV同等重要。

主要发现

  • 收缩压和舒张压BPV均与复发性卒中、主要心血管事件及全因死亡相关。
  • BPV与缺血性卒中的关联显著,与出血性卒中无关。
  • BPV每增加10点(收缩压SD,范围0-54.2),复发性缺血性卒中风险比1.15(95%CI 1.02-1.32;P=0.02)。
  • BPV每增加10点,主要心血管事件风险比1.19(95%CI 1.09-1.31;P<0.001)。
  • BPV每增加10点,全因死亡风险比1.24(95%CI 1.10-1.39;P<0.001)。

临床怎么用

  • 在既往卒中患者中,应关注血压变异性作为可改变的风险因素。
  • 未来需评估使用广泛可及且廉价的降压药物 actively 降低BPV是否能减少心血管疾病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Every year in the United States, almost 185 000 ischemic strokes occur in patients with a prior stroke. Recurrent stroke has significantly higher morbidity and mortality. Among modifiable risk factors for recurrent stroke, hypertension is the most prevalent. Reducing systolic blood pressure is standard of care for secondary stroke prevention. Recent literature suggests that increased blood pressure variability (BPV) is associated with primary stroke, although studies have not convincingly shown that it is associated with recurrent stroke, which was the goal of this analysis. Methods- We conducted a secondary analysis of 17 916 patients in the PRoFESS (Prevention Regimen for Effectively Avoiding Second Strokes) trial, which is the largest trial of patients with potential recurrent stroke. We calculated BPV and evaluated its effect on recurrent stroke (composite and stratified by ischemic or hemorrhagic stroke), major cardiovascular events (death from cardiovascular causes, recurrent stroke, myocardial infarction, or new or worsening heart failure), and all-cause death. Results- Both systolic and diastolic BPV were associated with recurrent stroke, major cardiovascular events, and all-cause death. The association with stroke was significant for ischemic, but not hemorrhagic, stroke. For every 10-point increase in BPV (systolic SD, range =0-54.2), the hazard ratio for a recurrent ischemic stroke was 1.15 (95% CI, 1.02-1.32; P=0.02), for major cardiovascular events was 1.19 (95% CI, 1.09-1.31; P<0.001), and for all-cause death was 1.24 (95% CI, 1.10-1.39; P<0.001). Conclusions- Our study adds to the growing body of literature suggesting that BPV is an important and potentially modifiable risk factor for ischemic stroke, cardiovascular events, and all-cause death. Specifically, it is the first study to demonstrate that increased BPV is associated with recurrent ischemic stroke and that diastolic BPV can be as important as systolic BPV. Future work should focus on evaluating whether actively reducing BPV, using widely available and inexpensive antihypertensive medications, reduces the risk of cardiovascular disease.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. de Havenon A, Fino NF, Johnson B, et al. Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS. Stroke. 2019. PMID: 31537194. doi:10.1161/STROKEAHA.119.026293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。